Cargando…
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared a pandemic by the World Health Organization, and the identification of effective therapeutic strategy is a need of the hour to combat SARS-CoV-2 infection. In this...
Autores principales: | Loganathan, Tamizhini, Ramachandran, Srimathy, Shankaran, Prakash, Nagarajan, Devipriya, Mohan S, Suma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293190/ https://www.ncbi.nlm.nih.gov/pubmed/32566414 http://dx.doi.org/10.7717/peerj.9357 |
Ejemplares similares
-
Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
por: Yu, Wenhui, et al.
Publicado: (2022) -
Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
por: Dobbs Spendlove, Mauri, et al.
Publicado: (2023) -
COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning
por: Liu, Yang, et al.
Publicado: (2021) -
Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens
por: Naz, Sadia, et al.
Publicado: (2017) -
Construction of the gene regulatory network identifies MYC as a transcriptional regulator of SWI/SNF complex
por: Srikanth, Srimari, et al.
Publicado: (2020)